Pituitary adenoma…nomen omen?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-021-02785-z.pdf
Reference33 articles.
1. M.B.S. Lopes, The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 134, 521–535 (2017)
2. S.L. Asa, O. Casar-Borota, P. Chanson, E. Delgrange, P. Earls, S. Ezzat, A. Grossman, H. Ikeda, N. Inoshita, N. Karavitaki, M. Korbonits, E.R. Laws Jr., M.B. Lopes, N. Maartens, I.E. McCutcheon, O. Mete, H. Nishioka, G. Raverot, F. Roncaroli, W. Saeger, L.V. Syro, A. Vasiljevic, C. Villa, A. Wierinckx, J. Trouillas, From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr. Relat. Cancer 24, C5–C8 (2017). attendees of 14th Meeting of the International Pituitary Pathology Club AFN
3. K.K.Y. Ho, M. Fleseriu, J. Wass, A. van der Lely, A. Barkan, A. Giustina, F.F. Casanueva, A.P. Heaney, N. Biermasz, C. Strasburger, S. Melmed, A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22, 569–573 (2019)
4. S.L. Asa, S. Asioli, S. Bozkurt, O. Casar-Borota, L. Chinezu, N. Comunoglu, G. Cossu, M. Cusimano, E. Delgrange, P. Earls, S. Ezzat, N. Gazioglu, A. Grossman, F. Guaraldi, R.A. Hickman, H. Ikeda, M.L. Jaffrain-Rea, N. Karavitaki, I. Kraljevic, S. La Rosa, E. Manojlovic-Gacic, N. Maartens, I.E. McCutcheon, M. Messerer, O. Mete, H. Nishioka, B. Oz, S. Pakbaz, M. Pekmezci, A. Perry, L. Reiniger, F. Roncaroli, W. Saeger, F. Soylemezoglu, O. Tachibana, J. Trouillas, J. Turchini, S. Uccella, C. Villa, S. Yamada, S. Yarman, Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary 23, 322–325 (2020)
5. K.K.Y. Ho, M. Fleseriu, J. Wass, A. van der Lely, A. Barkan, A. Giustina, F.F. Casanueva, A.P. Heaney, N. Biermasz, C. Strasburger, S. Melmed, The tale in evolution: clarity, 21 consistency and consultation, not contradiction and confusion. Pituitary 23, 476–477 (2020)
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series;Expert Review of Endocrinology & Metabolism;2023-03-04
2. High-risk pituitary adenomas and strategies for predicting response to treatment;Hormones;2022-01-21
3. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area;International Journal of Molecular Sciences;2021-12-02
4. International Multicenter Validation Study of the SAGIT® Instrument in Acromegaly;The Journal of Clinical Endocrinology & Metabolism;2021-07-27
5. Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel;Endocrine;2021-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3